Effects of Smoking Status on Remission and Metabolic and Cognitive Outcomes in Schizophrenia Patients Treated with Clozapine

Conclusions Smoking behavior among clozapine-treated schizophrenia
patients might delineate a cohort with an earlier onset of the disease.
Nevertheless, most findings comparing disease-specific and clinical outcomes
among smokers and nonsmokers were negative. Further research is needed to
identify strategies to overcome insufficient remission rates in this patient
group. [...] © Georg Thieme Verlag KG Stuttgart · New YorkArticle in Thieme eJournals: Table of contents  |  Abstract  |  Full text

Source: Pharmacopsychiatry - August 4, 2020 Category: Psychiatry Authors: Wagner, Elias Oviedo-Salcedo, Tatiana Pelzer, Nicola Strube, Wolfgang Maurus, Isabel Gutwinski, Stefan Schreiter, Stefanie Kleymann, Phillip Morgenroth, Carla-Lou Okhuijsen-Pfeifer, Cynthia Luykx, Jurjen J. Falkai, Peter Schneider-Axmann, Thomas Hasan, Al Tags: Original Paper Source Type: research